Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients [Phase 2]
Phase 2 clinical trial update evaluating low-dose venetoclax with itraconazole and TACL for relapsed/refractory acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia [Phase 3]
Phase 3 trial evaluating addition of blinatumomab to standard chemotherapy in newly diagnosed BCR-ABL-negative B-lineage acute lymphoblastic…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial evaluating sapanisertib in adults with relapsed or refractory acute lymphoblastic leukemia; results were posted in Ma…